Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Bharat Immunologicals & Biologicals Corporation Ltd. Share Price
Day's Range
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹18.21 |
|---|---|
| Day's Range | ₹17.22 - ₹18.50 |
| Open | ₹17.40 |
| 52 Week Range | ₹14.10 - ₹25.00 |
| Volume | 55,860 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 10.17 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 0.00 |
| TTM EPS (₹) | -3.85 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 0.00 |
| PAT Margin (%) | -37.30 |
| Face Value (₹) | 10.00 |
| ROCE(%) | -25.63 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 264.8 | 783.88 |
| Expenses | 0.0 | 0.0 |
| PBT | -39.59 | -96.88 |
| Operating profit | 0.0 | 0.0 |
| Net profit | -30.83 | -87.54 |
About Bharat Immunologicals & Biologicals Corporation Ltd.
| Founded | 1989 |
|---|---|
| Managing Director | Dhananjay Kumar Tiwary |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,40,793.82 | 1,862.70 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,78,956.35 | 6,776.50 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,49,819.64 | 4,442.55 | 3,140.10 - 3,140.10 |
| Apollo Hospitals Enterprise Ltd. | 1,22,170.95 | 8,480.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,09,370.14 | 1,415.30 | 1,165.70 - 1,165.70 |
| Lupin Ltd. | 1,07,536.52 | 2,344.95 | 1,836.80 - 1,836.80 |
| Zydus Lifesciences Ltd. | 1,06,822.69 | 1,084.35 | 835.50 - 835.50 |
| Max Healthcare Institute Ltd. | 1,06,672.39 | 1,093.50 | 903.00 - 903.00 |
| Dr. Reddy's Laboratories Ltd. | 1,06,133.20 | 1,291.90 | 1,148.40 - 1,148.40 |
| Mankind Pharma Ltd. | 99,835.58 | 2,537.05 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Krebs Biochemicals & Industries informs about trading window closure
Everest Organics informs about resignation of CS cum CO
Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI LODR Regulations’) and the SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, Everest Organics has informed that, Shweta Singh, Company Secretary and Compliance Officer of the company, has tendered her resignation from the position of Company Secretary (CS) and Compliance Officer (CO) of the Company with effect from June 22, 2026, citing personal reasons and better career prospects. The resignation letter (email) of Ms. Shweta Singh has been received by the Company on June 21, 2026 and the same shall be placed before the upcoming Board Meeting for formal acceptance and taking note thereof, in accordance with the applicable provisions of the Companies Act, 2013 and the SEBI LODR Regulations. The details as required under SEBI Circular are enclosed. The Company will make necessary arrangements for appointment of a new Company Secretary and Compliance Officer in accordance with the applicable provisions of law and will intimate the stock exchange(s) accordingly and till such time the Managing Director of the Company will be designated as Compliance Officer of the Company.
The above information is a part of company’s filings submitted to BSE.
Ipca Laboratories informs about trading window closure
Aurobindo Pharma informs about press release
Aurobindo Pharma has informed that it enclosed a copy of the Press Release that is being issued by the Company in connection with receipt of approval by Aurobindo Pharma USA, Inc. (‘Aurobindo USA’), a wholly owned subsidiary of the Company from the U.S. Federal Trade Commission (FTC) to proceed with the acquisition of Lannett Company LLC (‘Lannett’).
The above information is a part of company’s filings submitted to BSE.
Dr Reddys Laboratories informs about press release
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Bharat Immunologicals & Biologicals Corporation Ltd. is ₹18.21 as of 2026-06-22.
The market capitalisation of Bharat Immunologicals & Biologicals Corporation Ltd. is ₹75.05 as of 2026-06-19.
The 1-year return of Bharat Immunologicals & Biologicals Corporation Ltd. is -6.11% as of 2025-06-20.
The P/E ratio of Bharat Immunologicals & Biologicals Corporation Ltd. is 0.00 as of 2026-06-22.
The 52-week high and low of Bharat Immunologicals & Biologicals Corporation Ltd. are ₹25.00 and ₹14.10, respectively, as of 2026-06-22.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
